Bronchodilator reversibility testing in COPD

被引：1
|
作者：
Cotes, JE [1 ]
机构：
[1] Med Sch Newcastle Upon Tyne, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源：
THORAX | 2004年 / 59卷 / 02期
关键词：
D O I：
10.1136/thorax.2003.014712
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [21] Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD
    O'Donnell, D. E.
    Laveneziana, P.
    Ora, J.
    Webb, K. A.
    Lam, Y-M
    Ofir, D.
    THORAX, 2009, 64 (03) : 216 - 223
  • [22] Bronchodilator reversibility in asthma and COPD: findings from three large population studies
    Janson, Christer
    Malinovschi, Andrei
    Amaral, Andre F. S.
    Accordini, Simone
    Bousquet, Jean
    Buist, A. Sonia
    Canonica, Giorgio Walter
    Dahlen, Barbro
    Garcia-Aymerich, Judith
    Gnatiuc, Louisa
    Kowalski, Marek L.
    Patel, Jaymini
    Tan, Wan
    Toren, Kjell
    Zuberbier, Torsten
    Burney, Peter
    Jarvis, Deborah
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (03)
  • [23] Bronchodilator Reversibility Testing Selection Criteria and Interpretation in Allergy Office Settings
    Binoy, Rithik
    Anant, Shruti
    Sekhsaria, Sudhir
    Sharif, Naba A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB209 - AB209
  • [24] Residual reversibility in COPD patients already on long-acting bronchodilator: The OscilloRevers Study
    Le Rouzic, Olivier
    Picaud, Marjorie
    Salvator, Helene
    Bautin, Nathalie
    Devillier, Philippe
    Perez, Thierry
    RESPIRATORY MEDICINE AND RESEARCH, 2024, 85
  • [25] Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD
    Chou, Kun-Ta
    Su, Kang-Cheng
    Hsiao, Yi-Han
    Huang, Shiang-Fen
    Ko, Hsin-Kuo
    Tseng, Ching-Min
    Su, Vincent Yi-Fong
    Perng, Diahn-Warng
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (10): : 547 - 553
  • [26] Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD
    Lee, DKC
    EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (02) : 332 - 332
  • [27] Forced Vital Capacity Reversibility Post-Bronchodilator Is Associated with Dynamic Hyperinflation on Stage 1 Cardiopulmonary Exercise Testing in Patients with COPD
    Kouri, A.
    Stanbrook, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [28] Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
    Ahmed, Mona Ibrahim
    Ahmed, Randa Ibrahim
    Osama, Hasnaa
    Khalifa, Amira Karam
    Alshehri, Abdullah Ali
    Batiha, Gaber El-Saber
    Negm, Walaa A.
    Kamal, Marwa
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [29] Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
    Mona Ibrahim Ahmed
    Randa Ibrahim Ahmed
    Hasnaa Osama
    Amira Karam Khalifa
    Abdullah Ali Alshehri
    Gaber El-Saber Batiha
    Walaa A Negm
    Marwa Kamal
    BMC Pulmonary Medicine, 23
  • [30] Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol
    Lipworth, BJ
    Jackson, CM
    CHEST, 2002, 121 (04) : 1382 - 1382
12345